These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3517883)

  • 1. Pharmacological evaluation of 5-(Z,E)-13,14-didehydro-20-methyl-carboprostacyclin (FCE 22509).
    Ceserani R; Grossoni M; Ukmar G; Colombo M; Mongelli N
    Prostaglandins Leukot Med; 1986 Mar; 21(3):231-45. PubMed ID: 3517883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of PGI2 and two analogues (FCE 21292 and FCE 21258) in vitro and in vivo.
    Morley J; Page CP; Paul W; Mongelli N; Ceserani R; Gandolfi C
    Prostaglandins Leukot Med; 1983 Aug; 11(4):391-9. PubMed ID: 6353424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet and other effects of carboprostacyclin--a stable prostacyclin analogue.
    Adaikan PG; Karim SM; Lau LC
    Prostaglandins Med; 1980 Oct; 5(4):307-20. PubMed ID: 7003626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression and excitation induced in mice by two geometric isomers of (+)13,14-didehydro-20-methyl-carboprostacyclin, FCE 22177 and FCE 22176. Comparison with effects on blood pressure and platelet aggregation.
    Caparrotta L; Ceserani R; Mongelli N; Santi-Soncin E; Ragazzi E; Fassina G
    Prostaglandins; 1987 Mar; 33(3):351-62. PubMed ID: 3033748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. dl-9a-Deoxy-9a-methylene-PGI2 (a stable prostacyclin derivative): preliminary pharmacological data.
    Ceserani R; Grossoni M; Longiave D; Mizzotti B; Pozzi O; Dembinska-Kiec A; Bianco S
    Prostaglandins Med; 1980 Aug; 5(2):131-9. PubMed ID: 6251496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of FCE 22176, a stable prostacyclin analogue, with different prostaglandins in guinea-pig trachea and atria.
    Ragazzi E; Salvadori S; Froldi G
    Pharmacol Res; 1990; 22(3):263-9. PubMed ID: 2114614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG'S).
    Omini C; Moncada S; Vane JR
    Prostaglandins; 1977 Oct; 14(4):625-32. PubMed ID: 339280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardiovascular and platelet actions of 9 beta-methyl carbacyclin (ciprostene), a chemically stable analogue of prostacyclin, in the dog and monkey.
    Allan G; Follenfant MJ; Lidbury P; Oliver PL; Whittle BJ
    Br J Pharmacol; 1985 Jun; 85(2):547-55. PubMed ID: 3896365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of platelet aggregation by a new agent, 5-(Z,E)-13,14-didehydro-20-methyl-carbo PGI2 (FCE 22509).
    Bergamaschi M; Pierucci L; Ferti C; Corsi G; Branzoli U; Mandelli V
    Prostaglandins Leukot Med; 1984 Oct; 16(1):19-27. PubMed ID: 6393142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological properties of MM-706, a new prostacyclin derivative.
    Ragazzi E; Chinellato A; Lille U; Lopp M; Doni MG; Fassina G
    Gen Pharmacol; 1995 Jul; 26(4):703-9. PubMed ID: 7635245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues.
    Dong YJ; Jones RL; Wilson NH
    Br J Pharmacol; 1986 Jan; 87(1):97-107. PubMed ID: 2420404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular actions in vitro and cardioprotective effects in vivo of nileprost, a mixed type PGI2/PGE2 agonist.
    Darius H; Thomsen T; Schrör K
    J Cardiovasc Pharmacol; 1987 Aug; 10(2):144-52. PubMed ID: 2441164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical evaluation of the in vivo selectivity between hypotensive and platelet antiaggregating actions of iloprost and prostacyclin in beagle dogs.
    Hermán F; Hadházy P; Magyar K
    Arch Int Pharmacodyn Ther; 1989; 300():281-91. PubMed ID: 2482710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relaxation by prostacyclin (PGI2) and 7-oxo-PGI2 of isolated cerebral, coronary and mesenteric arteries.
    Malomvölgyi B; Hadházy P; Magyar K; Kánai K; Simonidesz V
    Acta Physiol Acad Sci Hung; 1982; 60(4):251-6. PubMed ID: 6764858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological properties of the new stable prostacyclin analogue 3-Oxa-methano-prostaglandin I.
    Yamamoto T; Satoh K; Nishimura T; Horikawa N; Mine T; Hirohashi T; Hara Y
    Arzneimittelforschung; 1994 Apr; 44(4):483-90. PubMed ID: 8011001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of receptors involved in the direct and indirect actions of prostaglandins E and I on the guinea-pig ileum.
    Lawrence RA; Jones RL; Wilson NH
    Br J Pharmacol; 1992 Feb; 105(2):271-8. PubMed ID: 1559125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of some pharmacological actions of prostaglandin E1, 6-oxo-PGE1 and PGI2.
    Adaikan PG; Tai NY; Lau LC; Karim SM; Kottegoda SR
    Prostaglandins; 1984 Apr; 27(4):505-16. PubMed ID: 6203140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the vasodepressor action of ZK 36 374, a stable prostacyclin derivative, PGI2 and PGE1 with their effect on platelet aggregation and bleeding time in rats.
    Casals-Stenzel J; Buse M; Losert W
    Prostaglandins Leukot Med; 1983 Feb; 10(2):197-212. PubMed ID: 6189133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of platelet aggregation with intravenous and oral administration of carboprostacyclin in man.
    Karim SM; Adaikan PG; Lau LC; Tai MY
    Prostaglandins Med; 1981 May; 6(5):521-7. PubMed ID: 7022510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The orally active thia-imino-prostacyclin Hoe 892: antiaggregatory and cardiovascular activities.
    Schölkens BA; Gehring D; Jung W
    Prostaglandins Leukot Med; 1983 Mar; 10(3):231-56. PubMed ID: 6405394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.